-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, URxHQIYQgr40Z5QQd9CGDnKQh53dqw85VmPFyMr1ZzL5eBKvMTpCOkIRECQcuVin Q2Rb677YRUBEezImMfh3kA== 0001266375-06-000103.txt : 20061114 0001266375-06-000103.hdr.sgml : 20061114 20061114131108 ACCESSION NUMBER: 0001266375-06-000103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061110 FILED AS OF DATE: 20061114 DATE AS OF CHANGE: 20061114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ISRAEL ROBERT J CENTRAL INDEX KEY: 0001250274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 061213174 MAIL ADDRESS: STREET 1: 50 OXFORD DR CITY: MONTEBELLE STATE: NY ZIP: 10901 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-11-10 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250274 ISRAEL ROBERT J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 Sr. VP, Medical Affairs Common Stock 2006-11-10 4 M 0 5000 4 A 31690 D Common Stock 2006-11-10 4 S 0 5000 28 D 26690 D Non-Qualified Stock Option (right to buy) 4 2006-11-10 4 M 0 5000 0 D 2002-03-31 2007-04-01 Common Stock 5000 10000 D Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer. The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer. Robert J. Israel 2006-11-14 -----END PRIVACY-ENHANCED MESSAGE-----